PYXS - Pyxis Oncology, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
3.24 0.47 (14.51%)	---	-0.03 (-0.8%)	-0.01 (-0.27%)	0.0 (0.0%)	0.42 (12.77%)	0.04 (1.09%)	0.04 (1.09%)

Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: Closed

Earnings & Ratios

Basic EPS:: -0.3
Diluted EPS:: -0.3
Basic P/E:: -12.3667
Diluted P/E:: -12.3667
RSI(14) 1m:: 33.5
VWAP:: 3.71
RVol:: 0.8777

Events

Period	Kind	Movement	Occurred At
Day	Price increase day	3.58 +0.34 (+10.63%)	Oct 15 15:11
1m	Price increase 1m	3.56 +0.04 (+1.14%)	Oct 15 12:25
1m	Price increase 1m	3.51 +0.03 (+1.01%)	Oct 15 12:04
1m	Price increase 1m	3.54 +0.04 (+1.14%)	Oct 15 11:15
1m	Price decrease 1m	3.44 -0.04 (-1.15%)	Oct 15 10:40